BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30729260)

  • 1. Characteristics and Outcomes of Heart Transplantation in DiGeorge Syndrome.
    Woolman P; Bearl DW; Soslow JH; Dodd DA; Thurm C; Hall M; Feingold B; Godown J
    Pediatr Cardiol; 2019 Apr; 40(4):768-775. PubMed ID: 30729260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Transplantation in Children with Turner Syndrome: Analysis of a Linked Dataset.
    Chew JD; Soslow JH; Thurm C; Hall M; Dodd DA; Feingold B; Simmons J; Godown J
    Pediatr Cardiol; 2018 Mar; 39(3):610-616. PubMed ID: 29299618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice Variation, Costs and Outcomes Associated with the Use of Inhaled Nitric Oxide in Pediatric Heart Transplant Recipients.
    Bearl DW; Dodd DA; Thurm C; Hall M; Soslow JH; Feingold B; Godown J
    Pediatr Cardiol; 2019 Mar; 40(3):650-657. PubMed ID: 30547294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal membrane oxygenation use in the first 24 hours following pediatric heart transplantation: Incidence, risk factors, and outcomes.
    Godown J; Bearl DW; Thurm C; Hall M; Feingold B; Soslow JH; Mettler BA; Smith AH; Profita EL; Singh TP; Dodd DA
    Pediatr Transplant; 2019 Jun; 23(4):e13414. PubMed ID: 30973190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of third heart transplants in pediatric and young adult patients: analysis of the United Network for Organ Sharing database.
    Friedland-Little JM; Gajarski RJ; Yu S; Donohue JE; Zamberlan MC; Schumacher KR
    J Heart Lung Transplant; 2014 Sep; 33(9):917-23. PubMed ID: 24861821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric heart transplantation: 23-year single-center experience.
    Huebler M; Schubert S; Lehmkuhl HB; Weng Y; Miera O; Alexi-Meskishvili V; Berger F; Hetzer R
    Eur J Cardiothorac Surg; 2011 May; 39(5):e83-9. PubMed ID: 21354807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart Transplantation for Pediatric and Congenital Cardiac Disease: A Comparison of Two Eras over 23 Years and 188 Transplants at a Single Institution.
    Tuite GC; Quintessenza JA; Asante-Korang A; Ghazarian SR; Wisotzkey BL; Shah S; Stapleton GE; Decker JA; Herbert CE; Kartha V; Alexander P; Carapellucci J; Krasnopero D; Hanson J; Goldenberg NA; Do NL; Mavroudis C; Karl TR; Boucek RJ; Kutty S; Vricella LA; van Gelder HM; Jacobs JP
    World J Pediatr Congenit Heart Surg; 2021 Jan; 12(1):17-26. PubMed ID: 33407028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart transplantation: 25 years' single-centre experience.
    Bruschi G; Colombo T; Oliva F; Botta L; Morici N; Cannata A; Vittori C; Turazza F; Garascia A; Pedrazzini G; Frigerio M; Martinelli L
    J Cardiovasc Med (Hagerstown); 2013 Sep; 14(9):637-47. PubMed ID: 23340045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance steroid use at 30 days post-transplant and outcomes of pediatric heart transplantation: A propensity matched analysis of the Pediatric Heart Transplant Study database.
    Auerbach SR; Kukreja M; Gilbert D; Bastardi H; Feingold B; Knecht K; Kaufman BD; Brown RN; Miyamoto SD
    J Heart Lung Transplant; 2015 Aug; 34(8):1066-72. PubMed ID: 25980572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation.
    Grupper A; Grupper A; Daly RC; Pereira NL; Hathcock MA; Kremers WK; Cosio FG; Edwards BS; Kushwaha SS
    J Heart Lung Transplant; 2017 Mar; 36(3):297-304. PubMed ID: 27642059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients.
    Thrush PT; Gossett JG; Costello JM; Matthews KL; Nubani R; Bhagat H; Backer CL; Pahl E
    Pediatr Transplant; 2014 Feb; 18(1):79-86. PubMed ID: 24283506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome after pediatric heart transplantation: two decades of a single center experience.
    Gambino A; Cerutti A; Feltrin G; Toscano G; Tarantini G; Milanesi O; Angelini A; Gerosa G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):220-4. PubMed ID: 17590347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal.
    Doesch AO; Müller S; Konstandin M; Celik S; Kristen A; Frankenstein L; Ehlermann P; Sack FU; Katus HA; Dengler TJ
    Transplant Proc; 2010 Nov; 42(9):3694-9. PubMed ID: 21094840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported Nonadherence to Immunosuppressive Medication in Young Adults After Heart Transplantation: A Retrospective Analysis of a National Registry.
    Tumin D; McConnell PI; Galantowicz M; Tobias JD; Hayes D
    Transplantation; 2017 Feb; 101(2):421-429. PubMed ID: 26950728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression.
    Groetzner J; Kaczmarek I; Mueller M; Huber S; Deutsch A; Daebritz S; Arbogast H; Meiser B; Reichart B
    J Heart Lung Transplant; 2005 Nov; 24(11):1787-92. PubMed ID: 16297783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy.
    Rivinius R; Helmschrott M; Ruhparwar A; Schmack B; Klein B; Erbel C; Gleissner CA; Akhavanpoor M; Frankenstein L; Darche FF; Thomas D; Ehlermann P; Bruckner T; Katus HA; Doesch AO
    Drug Des Devel Ther; 2015; 9():93-102. PubMed ID: 25552900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting graft loss by 1 year in pediatric heart transplantation candidates: an analysis of the Pediatric Heart Transplant Study database.
    Schumacher KR; Almond C; Singh TP; Kirk R; Spicer R; Hoffman TM; Hsu D; Naftel DC; Pruitt E; Zamberlan M; Canter CE; Gajarski RJ;
    Circulation; 2015 Mar; 131(10):890-8. PubMed ID: 25587099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Survival After Heart Transplantation in Children and Young Adults: A 22-Year Study of 179 Transplants.
    Shah S; Asante-Korang A; Ghazarian SR; Stapleton G; Herbert C; Decker J; Almodovar MC; Karl TR; Do NL; Quintessenza JA; Mavroudis C; Vricella LA; van Gelder HM; Kartha V; Alexander P; Carapellucci J; Krasnopero D; Hanson J; Amankwah E; Roth J; Jacobs JP
    World J Pediatr Congenit Heart Surg; 2018 Sep; 9(5):557-564. PubMed ID: 30157732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Listing Low-Weight or Ill Infants for Heart Transplantation: Is It Prudent?
    Rizwan R; Zafar F; Chin C; Tweddell J; Bryant R; Morales D
    Ann Thorac Surg; 2018 Oct; 106(4):1189-1196. PubMed ID: 30009801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results.
    Guethoff S; Stroeh K; Grinninger C; Koenig MA; Kleinert EC; Rieger A; Mayr T; von Ziegler F; Reichart B; Hagl C; Schramm R; Kaczmarek I; Meiser BM
    J Heart Lung Transplant; 2015 May; 34(5):634-42. PubMed ID: 25701373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.